Jeff Aronin recognizes Evozyne for unlocking the potential of novel proteins
Evozyne, a portfolio company of Paragon Biosciences, announced that a peer-reviewed publication in the journal Science demonstrates successful use of its world-class molecular engineering technology to create never-before-seen proteins with exceptionally advanced functionality. The Chicago-based… Read more